LENZ reports Q2 2026 results as VIZZ adds telehealth access and global filings expand
LENZ posted $5.5 million in Q2 2026 revenue and launched telehealth prescribing for VIZZ, while regulatory submissions advanced in the UK, Canada and Saudi Arabia.
SEC filing